Spatiotemporal modelling of pregabalin prescribing in England with effect of deprivation
Open Access
- 1 March 2020
- Vol. 10 (3), e029624
- https://doi.org/10.1136/bmjopen-2019-029624
Abstract
Objective This paper aims to understand spatial and temporal trends in pregabalin prescribing and the relationship with deprivation across England at both general practice and clinical commissioning group (CCG) levels. Design A set of 207 independent generalised additive models are employed to model the spatiotemporal trend of pregabalin prescribed and dispensed per 1000 population, adjusting for deprivation. The response variable is pregabalin prescribed in milligrams, with weighted Index of Multiple Deprivation (IMD), geographical location and time as predictors. The set of active prescribing facilities grouped within CCG is the unit of analysis. Setting National Health Service open prescribing data; all general practices in England, UK between January 2015 and June 2017. Population All patients registered to general practices in England, UK. Results Adjusting for deprivation, a North-South divide is shown in terms of prescribing trends, with the North of England showing increasing prescribing rates during the study period on average, while in the South of England rates are on average decreasing. Approximately 60% of general practices showed increasing prescribing rate, with the highest being 4.03 (1.75 for the most decreasing). There were no apparent spatial patterns in baseline prescription rates at the CCG level. Weighted IMD score proved to be statistically significant in 138 of 207 CCGs. Two-thirds of CCGs showed more pregabalin prescribed in areas of greater deprivation. Whether the prescribing rate is high due to high baseline prescription rate or increasing rates needs to be specifically looked at. Conclusions The spatial temporal modelling demonstrated that the North of England has a significantly higher chance to see increase in pregablin prescriptions compared with the South, adjusted for weighted IMD. Weighted IMD has shown positive impact on pregabalin prescriptions for 138 CCGs.This publication has 22 references indexed in Scilit:
- Chronic Pain in the Emergency Department: A Pilot Mixed-Methods Cross-Sectional Study Examining Patient Characteristics and Reasons for PresentationsPain Research and Management, 2016
- Misuse of gabapentin and pregabalin: a marker for a more serious malaise?Addiction, 2016
- Systematic Review of Multidisciplinary Chronic Pain Treatment FacilitiesPain Research and Management, 2016
- Misuse and Abuse of Pregabalin and Gabapentin: Cause for Concern?CNS Drugs, 2014
- Bad medicine: gabapentin and pregabalinBMJ, 2013
- Factors associated with pregabalin dispensing at higher than the approved maximum doseEuropean Journal of Clinical Pharmacology, 2013
- The pain of pregabalin prescribing in prisonsBritish Journal of General Practice, 2013
- Mapping English GP prescribing data: a tool for monitoring health-service inequalitiesBMJ Open, 2013
- Potential for pregabalin abuse or diversion after past drug-seeking behavior.2010
- Pregabalin Abuse, Dependence, and Withdrawal: A Case ReportAmerican Journal of Psychiatry, 2010